Sensai
Reading the tape…Pulling live market data…Setting the scene…
Sensai
AI Stock Dissection
AI Stock Dissection
MAXHEALTH
Mr. Abhay Soi · Gurugram, India
₹1,124.80
▲+1.21%MaxHealth's shares are trading near the 1-year highs, driven by the healthcare sector's recovery and growing expectations for the company's steady revenue growth
Exchange
NSI
Currency
INR
Day range
₹1,110.30 – ₹1,135.90
52-week range
₹903.00 – ₹1,301.70
Sector
Healthcare
Industry
Medical Care Facilities
AI investment rating
AI analysis85% confidence
MaxHealth's current valuation appears rich vs its mid-cap peers and the broader NSE 500, but may be justified by its steady growth prospects and improving profitability
13.6% below the 1-year high · trend up
Hedge-fund memo
Today
Shares surged 1.21% amidst a broad-based market rally, with volumes slightly above average
This week
After touching 1-year highs, shares corrected slightly, trading in the upper third of their 1-year range, with volumes above average
This month
Shares have outperformed the NSE 50 index in the last 30 days, with the company's revenue growth expectations driving the price increase
Bull thesis
Bear thesis
Narrative read
Bullish
Composite sentiment
Institutional
Buy
Retail
Moderately Bullish
News flow
Positive, driven by company-specific developments
Read
High institutional ownership and growing retail interest
Live news feed unavailable right now — showing the AI's qualitative read instead. Not scraped platform data.
Smart money
Named holders aren't published for this listing (common for Indian stocks). The split at left is live.
Financial health
Profitability
Growth
Balance sheet
Financial statements
Earnings intelligence
Beat estimates in 1 of 4 recent quarters (EPS actual vs. consensus).
3.5 vs 4.17583
-16.18% surprise
3.4989 vs 3.83402
-8.74% surprise
5.02 vs 4.15041
20.95% surprise
Competitive landscape
| Company | Market cap | P/E | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| MAXHEALTH | 1.09T | 76.10 | 14.33% | 22.68% | 12.20% |
| APOLLOHOSP | 1.29T | 66.62 | 21.50% | 11.91% | 18.10% |
| NH | 422.51B | 52.06 |
Technical intelligence
Volume
RSI (14) · 70 overbought / 30 oversold
MACD (12,26,9) · MACD vs signal
Candlesticks, volume, RSI and MACD from 499sessions of real Yahoo daily data. Moving averages use full history, so they're accurate at the left edge. Support / resistance are the 52-week low / high. Educational — technical signals are not buy or sell calls.
Risk intelligence
Market competition and regulatory challenges impacting revenue and profitability
Mitigation: Focus on operational efficiency improvements, investments in technology, and strategic partnerships
Business intelligence
Competitive moat
MaxHealth's extensive hospital network, diversified services offerings, and focus on operational efficiency improvements create a strong competitive moat
Supply chain
Upstream (inputs / suppliers)
↓
Downstream (customers / markets)
M&A / strategic moves
Catalyst calendar
Q4FY22 results, expected to demonstrate improved revenue growth and profitability
Thesis builder
Bull case
Revenue growth accelerates above 15% YoY, driven by increased hospital network and services offerings
Base case
Revenue growth continues to trend around 12% YoY, driven by steady market expansion and operational improvements
Bear case
Revenue growth decelerates below 10% YoY, driven by increased competition, higher regulatory costs, or a downturn in the broader market
Time horizon
2026, with a potential target for 15 hospitals with a total bed capacity of 2,500 beds
Est. CAGR
15-18%
Entry (qual.)
Investors can consider investing in the company when it corrects 10-15% below the current price level, indicating a buying opportunity
Exit (qual.)
Investors should look to exit their position when the P/E ratio exceeds 80 or the stock price surges 20% above its current levels
Knowledge graph
Executives & sector are live; peers are clickable → their dissection. Institutional holders shown where the exchange publishes them.
Portfolio impact
Enter tickers + weights, then see how MAXHEALTH fits.
Scenario simulator
Simulate a macro shock and see the illustrative impact:
Tailwind for tech & enablers.
Illustrative impact
Medium prob.Directional illustration only — not modelled on this company's actuals. A real simulator needs company financials.
Explain like…
Re-explain MAXHEALTH for a different audience:
Pick a persona to get a tailored explanation.
Sensai publishes educational market commentary, not investment advice. We are not SEBI-registered investment advisers or research analysts, and nothing here is a recommendation to buy, sell, or hold any security.
Live prices, index levels, and other market data are pulled from third-party feeds, may be delayed, and can be inaccurate or unavailable. Do not rely on them for trading decisions.
Investing in equities carries risk, including the loss of principal. Always do your own research and consider consulting a SEBI-registered adviser before making any investment decision.
Hidden risks
Hidden opportunities
Watch next
Investors should continue to focus on the company's revenue growth, profitability, and its plans to expand its hospital network
Annual income statement, oldest → newest. Live via Yahoo.
3.15 vs 3.89143
-19.05% surprise
| 19.84% |
| 13.72% |
| 75.80% |
| FORTIS | 716.34B | 68.76 | 11.01% | 16.84% | 17.80% |
Peers via Yahoo's similarity graph, same-sector first; fundamentals live. Ask the AI copilot below for a qualitative head-to-head.
Support (day/52w low)
₹1,110.30
Resistance (day/52w high)
₹1,135.90
Volume
16,10,670
Trend
up
RSI (14)
54
MACD
bearish
MA cross
golden
50-day MA
₹1,063.60
200-day MA
₹1,050.89
vs 200-DMA
7.0%
RSI/MACD computed from 6 months of daily closes; moving averages from Yahoo. Options positioning still needs an options feed.
Overall conviction 85%